17-Oxosteroid conjugates in plasma and urine of patients with acute intermittent porphyria.
D015068:17-Ketosteroids / Q000032:analysis* / Q000097:blood / Q000652:urine; D000624:5-Aminolevulinate Synthetase / Q000378:metabolism; D000328:Adult; D000728:Androgens / Q000494:pharmacology; D000738:Androsterone / Q000652:urine; D000818:Animals; D002849:Chromatography, Gas; D003907:Dexamethasone / Q000627:therapeutic use; D004967:Estrogens / Q000494:pharmacology; D005043:Etiocholanolone / Q000652:urine; D005260:Female; D006801:Humans; D007982:Levulinic Acids / Q000652:urine; D008099:Liver / Q000201:enzymology; D008297:Male; D008875:Middle Aged; D011162:Porphobilinogen / Q000652:urine; D011164:Porphyrias / Q000097:blood / Q000188:drug therapy / Q000378:metabolism* / Q000652:urine; D011372:Progestins / Q000494:pharmacology; D051381:Rats
D015068:17-Ketosteroids; D000728:Androgens; D004967:Estrogens; D007982:Levulinic Acids; D011372:Progestins; D011162:Porphobilinogen; D003907:Dexamethasone; D005043:Etiocholanolone; D000738:Androsterone; D000624:5-Aminolevulinate Synthetase